Home   中文简体 中文繁體 
Company News Products R&D Investor relationship Human Resource Contact Us
 
 
 
Share Price
Announcements
Results Announcement
Circulars
Notices of General Meetings
Other Information
Investor Communication
Contact
 
ANNOUNCEMENT OF OBTAINING CLINICAL TRIAL APPROVAL FOR HIGH BIO-ACTIVITY RECOMBINANT HUMAN TNF RECEPTOR   2014-05-20 16:25
Announcements and Notices
[Inside Information]
Download
Links  |  SiteMap  |  Privacy Copyright© Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2007
（沪）-非经营性-2024-0273    沪ICP备10027510号-1